Rapid Detection of Carbapenem-Producing and Enzyme Category in Enterobacterales through Ultraviolet Spectroscopy-Based Meropenem Hydrolysis Assessment
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Carbapenem-producing Enterobacterales (CPE) pose a serious global health threat. This study aimed to develop a rapid and cost-effective ultraviolet (UV) spectrophotometry-based assay for detecting carbapenem resistance and identifying the carbapenemase enzyme category in Enterobacterales, thereby substantially reducing diagnostic turnaround times. The assay quantified Meropenem hydrolysis using Δ A = A300–A340 and was evaluated using 137 Enterobacterales strains. The hydrolysis level, measured by residual Meropenem after 3 h at 37 °C, was used to assess resistance. The A300–A340 method showed strong agreement with standard disk diffusion and VITEK-2 Compact results. Furthermore, the inhibitory effect of EDTA on Meropenem hydrolysis was tested on 79 CPE strains (35 MBL-producing and 44 non-MBL-producing) to differentiate carbapenemase categories, with PCR serving as the reference. A strong linear correlation ( R 2 = 0.9934) was observed between Meropenem concentration and Δ A . The assay demonstrated 98.54% accuracy in detecting Meropenem resistance using an 85% Meropenem retention threshold, and both the hydrolysis and inhibitor enhancement assays showed 97.47% specificity for distinguishing MBL from non-MBL producers. In conclusion, this UV spectrophotometry-based assay provides a rapid, accurate, and economical approach for detecting carbapenem resistance and classifying carbapenemase type, offering great potential for improving CPE infection management and guiding antibiotic therapy.
Fields of Study & Subjects
Antibiotic Resistance in Bacteria
Bacterial Identification and Susceptibility Testing
Antibiotic Use and Resistance
Publication details
- Journal / source
- ACS Infectious Diseases
- Volume
- 12
- Issue
- 4
- Pages
- 1260–1268
- Publication date
- 1 April 2026
- Language
- EN